About NanoCellect Biomedical
NanoCellect Biomedical is a private company based in San Diego, California. It has reported $60,578,736 raised in five offerings on Form D since November 2015. Its chief executive is Chris Neary.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 16, 2023 | Jun 30, 2023 | $28,929,239of $38.5M target | 32 | $904K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 13, 2021 | Aug 27, 2021 | $20,000,001fully sold | 15 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Nov 22, 2017 | Dec 5, 2017 | $7,432,996of $7.5M target | 11 | $675K | EquityRule 506(b) | Form D ↗ |
| Aug 26, 2016 | Sep 2, 2016amended Jul 24, 2017 | $2,466,500of $3.0M target | 4 | $616K | Debt, Consists of Convertible Promissory Note convertible into shares of Preferred Stock of the Issuer.Rule 506(b) | Form D/A ↗1 earlier filing |
| Oct 30, 2015 | Nov 13, 2015amended Jan 22, 2016 | $1,750,000fully sold | 3 | $583K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, five offerings | $60,578,736 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NanoCellect Biomedical's Form D filed Jun 30, 2023.
JM
Jose Morachis
Executive officer
NB
Nicolas Barthelemy
Director
CN
Chris Neary
Chief Executive Officer and director
PC
Paul Conley
Director
JB
Jeremy Baker
Executive officer
Earlier filings also listed Kenneth Hood (director, last listed Aug 2021), Jack Ball (director, last listed Aug 2021), Alexis Ji (director, last listed Aug 2021), William Alaynick (executive officer and director, last listed Dec 2017) and Nate Heintzman (executive officer, last listed Dec 2017).